Patents by Inventor Michael Cuchiara
Michael Cuchiara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250001159Abstract: Systems and techniques for improving cardiorenal syndrome (CRS) may be provided. The systems may include a first flow enhancer configured to increase a renal artery pressure. The systems may include a second flow enhancer or flow restrictor configured to reduce a renal vein pressure. Each flow enhancer or flow restrictor may be configured to increase a transrenal pressure gradient, improve filtering and renal perfusion.Type: ApplicationFiled: June 28, 2024Publication date: January 2, 2025Applicant: ABIOMED, Inc.Inventors: Michael Cuchiara, Soo Young Kim, Sathya Dev Unudurthi, Ralf Westenfeld
-
Publication number: 20250001158Abstract: A system and method for cardiorenal syndrome (CRS) therapy are provided. The system may utilize a therapy-delivery device configured to be disposed within a patient. The therapy-delivery device may be, e.g., a blood pump, a blood flow or pressure restrictor or enhancer. The system may include a controller operably coupled to the therapy-delivery device. The controller may be configured to adjust a therapy delivered by the therapy-delivery device based on a parameter related to renal function. The parameter may be measured by a real-time diagnostic sensor. The real-time diagnostic sensor may be integral to the therapy-delivery device, or may be located remotely from the therapy-delivery device, such as on a separate implantable device, or on a wearable medical device.Type: ApplicationFiled: June 28, 2024Publication date: January 2, 2025Applicant: ABIOMED, Inc.Inventors: Michael Cuchiara, Soo Young Kim, Sathya Dev Unudurthi, Ralf Westenfeld
-
Patent number: 11623093Abstract: Neuromodulation is used to enhance left ventricular relaxation and/or left ventricular contractility, during contemporaneous use of a mechanical circulatory support device to increase cardiac output or aid in unloading the heart. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.Type: GrantFiled: May 18, 2021Date of Patent: April 11, 2023Assignee: NuXcel LimitedInventors: Michael Cuchiara, Stephen C. Masson
-
Systems and methods for generating therapeutic electric fields for capture of nervous system targets
Patent number: 11185699Abstract: A neuromodulation system includes neuromodulation electrodes on an electrode support that is positionable within a blood vessel for transvascular stimulation of target nerves. Cathode surface area, cathode-to-anode spacing, and other parameters are selected for capture of specific types of nerves (sympathetic, parasympathetic, and/or mixed nerves), nerves located at larger or shorter distances from the vascular wall, and also for proper nerve capture for the targeted types of nerves.Type: GrantFiled: October 17, 2017Date of Patent: November 30, 2021Assignee: NuXcel LimitedInventors: Stephen C Masson, Michael Cuchiara, Jean Darnieder -
Publication number: 20210275816Abstract: Neuromodulation is used to enhance left ventricular relaxation and/or left ventricular contractility, during contemporaneous use of a mechanical circulatory support device to increase cardiac output or aid in unloading the heart. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.Type: ApplicationFiled: May 18, 2021Publication date: September 9, 2021Applicant: NuXcel LimitedInventors: Michael Cuchiara, Stephen C. Masson
-
Patent number: 11033741Abstract: Neuromodulation is used to enhance left ventricular relaxation. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.Type: GrantFiled: January 31, 2018Date of Patent: June 15, 2021Assignee: NuXcel LimitedInventors: Michael Cuchiara, Stephen C Masson
-
Publication number: 20200282217Abstract: A catheter system configured for delivering a neuromodulation therapy, includes a first therapeutic element positionable in a first target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, azygos vein or azygos arch, and a second therapeutic element in a second target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, internal jugular vein, azygos vein or azygos arch. The system and associated method deliver therapeutic energy to at least one parasympathetic nerve fiber external to the first target vessel using the first therapeutic element, and deliver therapeutic energy to at least one sympathetic nerve fiber external to the second target vessel using the second therapeutic element.Type: ApplicationFiled: April 6, 2020Publication date: September 10, 2020Inventors: Stephen C. Masson, Michael Cuchiara, Efrain A. Miranda, Richard A. Glenn, A J. Rogers
-
SYSTEMS AND METHODS FOR GENERATING THERAPEUTIC ELECTRIC FIELDS FOR CAPTURE OF NERVOUS SYSTEM TARGETS
Publication number: 20200269052Abstract: A neuromodulation system includes neuromodulation electrodes on an electrode support that is positionable within a blood vessel for transvascular stimulation of target nerves. Cathode surface area, cathode-to-anode spacing, and other parameters are selected for capture of specific types of nerves (sympathetic, parasympathetic, and/or mixed nerves), nerves located at larger or shorter distances from the vascular wall, and also for proper nerve capture for the targeted types of nerves.Type: ApplicationFiled: October 17, 2017Publication date: August 27, 2020Inventors: Stephen C. Masson, Michael Cuchiara, Jean Darnieder -
Publication number: 20200164204Abstract: Electrode systems for transvascular stimulation of target nerves include electrode arrays, elements promoting blood flow between electrode surfaces and surrounding vascular walls, electrodes shaped to promote more even current density than electrodes having angular edges, features for retaining the electrode systems with blood vessels, and features for using electrode-carrying elements to asymmetrically distend blood vessel walls towards target nerve structures.Type: ApplicationFiled: December 2, 2019Publication date: May 28, 2020Inventors: Stephen C. Masson, Scott Purcell, Michael Cuchiara, Richard A. Glenn
-
Patent number: 10639478Abstract: Neuromodulation is used to enhance left ventricular relaxation. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.Type: GrantFiled: January 31, 2018Date of Patent: May 5, 2020Assignee: NeuroTronik IP Holding (Jersey) LimitedInventors: Michael Cuchiara, Stephen C Masson
-
Patent number: 10525260Abstract: Electrode systems for transvascular stimulation of target nerves include electrode arrays, elements promoting blood flow between electrode surfaces and surrounding vascular walls, electrodes shaped to promote more even current density than electrodes having angular edges, features for retaining the electrode systems with blood vessels, and features for using electrode-carrying elements to asymmetrically distend blood vessel walls towards target nerve structures.Type: GrantFiled: August 6, 2015Date of Patent: January 7, 2020Assignee: NeuroTronik IP Holding (Jersey) LimitedInventors: Stephen C Masson, Scott Purcell, Michael Cuchiara, Richard A. Glenn
-
Publication number: 20180214697Abstract: Neuromodulation is used to enhance left ventricular relaxation. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.Type: ApplicationFiled: January 31, 2018Publication date: August 2, 2018Applicant: NeuroTronik IP Holding (Jersey) LimitedInventors: Michael Cuchiara, Stephen C Masson
-
Publication number: 20180214696Abstract: Neuromodulation is used to enhance left ventricular relaxation. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.Type: ApplicationFiled: January 31, 2018Publication date: August 2, 2018Applicant: NeuroTronik IP Holding (Jersey) LimitedInventors: Michael Cuchiara, Stephen C. Masson
-
Publication number: 20180214698Abstract: Neuromodulation is used to enhance left ventricular relaxation. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.Type: ApplicationFiled: January 31, 2018Publication date: August 2, 2018Applicant: NeuroTronik IP Holding (Jersey) LimitedInventors: Michael Cuchiara, Stephen C. Masson
-
Publication number: 20180126151Abstract: Electrode systems for transvascular stimulation of target nerves include electrode arrays, elements promoting blood flow between electrode surfaces and surrounding vascular walls, electrodes shaped to promote more even current density than electrodes having angular edges, features for retaining the electrode systems with blood vessels, and features for using electrode-carrying elements to asymmetrically distend blood vessel walls towards target nerve structures.Type: ApplicationFiled: August 6, 2015Publication date: May 10, 2018Inventors: Stephen C Masson, Scott Purcell, Michael Cuchiara, Richard A. Glenn
-
Publication number: 20170312525Abstract: A catheter system configured for delivering a neuromodulation therapy, includes a first therapeutic element positionable in a first target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, azygos vein or azygos arch, and a second therapeutic element in a second target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, internal jugular vein, azygos vein or azygos arch. The system and associated method deliver therapeutic energy to at least one parasympathetic nerve fiber external to the first target vessel using the first therapeutic element, and deliver therapeutic energy to at least one sympathetic nerve fiber external to the second target vessel using the second therapeutic element.Type: ApplicationFiled: July 16, 2015Publication date: November 2, 2017Inventors: Stephen C. Masson, Michael Cuchiara, Efrain A. Miranda, Richard A. Glenn, A J. Rogers
-
Publication number: 20170189642Abstract: A catheter system configured for delivering a neuromodulation therapy, includes a first therapeutic element positionable in a first target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, azygos vein or azygos arch, and a second therapeutic element in a second target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, azygos vein or azygos arch. The system and associated method deliver therapeutic energy to at least one parasympathetic nerve fiber external to the first target vessel using the first therapeutic element, and deliver therapeutic energy to at least one sympathetic nerve fiber external to the second target vessel using the second therapeutic element.Type: ApplicationFiled: March 9, 2015Publication date: July 6, 2017Inventors: Stephen C. Masson, Michael Cuchiara, Efrain A. Miranda, Richard A. Glenn, A J. Rogers